Consolidated Statement Of Profit Or Loss

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7271855

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
1,170,611,000,000 JPY
1,111,367,000,000 JPY
Cost of sales
339,409,000,000 JPY
413,306,000,000 JPY
Gross profit
831,201,000,000 JPY
698,061,000,000 JPY
Selling, general and administrative expenses
110,098,000,000 JPY
112,580,000,000 JPY
Operating profit (loss)
542,002,000,000 JPY
439,174,000,000 JPY
Finance costs
-5,000,000 JPY
27,000,000 JPY
Profit (loss) before tax
543,034,000,000 JPY
443,821,000,000 JPY
Income tax expense
155,717,000,000 JPY
118,349,000,000 JPY
Profit (loss)
JPY
387,317,000,000 JPY
387,317,000,000 JPY
JPY
387,317,000,000 JPY
JPY
325,472,000,000 JPY
325,472,000,000 JPY
JPY
JPY
325,472,000,000 JPY
JPY
Profit (loss) attributable to
Owners of parent
387,317,000,000 JPY
325,472,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
235.39
197.83
Diluted earnings (loss) per share
235.36
197.80

Talk to a Data Expert

Have a question? We'll get back to you promptly.